Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price traded down 4.4% during trading on Friday . The company traded as low as $15.60 and last traded at $15.62. 3,839 shares were traded during trading, a decline of 79% from the average session volume of 18,023 shares. The stock had previously closed at $16.34.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a "buy" rating and a $21.00 price objective for the company. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a report on Tuesday, November 19th.
Get Our Latest Research Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Stock Down 3.2 %
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Articles
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
